The PGA Tour has announced major changes to its Anti-Doping Program to include blood testing and publicly naming players who have tested positive for recreational drugs.
The revisions, which come into effect at the beginning of next season, better reflect the policies and updated prohibited drugs list issued by the World Anti-Doping Agency.
While the Tour already discloses information regarding the abuse of performance enhancing substances, starting in October the public will also be made aware of players who have tested positive to recreational drugs.
“Beginning with the 2017-18 PGA Tour season, suspensions related to violations of the program, whether for performance enhancing substances or drugs of abuse, will be reported publicly,” the PGA Tour said in a statement.
“Once the adjudication process has been completed, the Tour will issue a statement containing the name of the player, the fact that a violation for either a performance enhancing substance or a drug of abuse has occurred and the length of the suspension.”
Urine samples will still be used for the bulk of drug tests, but the introduction of blood testing will allow for more comprehensive results.
“While the vast majority of the substances on the Prohibited List are best detected through urine testing, there are some, like Human Growth Hormone, that are only detected through blood.”
The Tour’s list of banned substances will now include asthma medications, allergy and anti-inflammatory medications, and pseudoephedrine over a designated threshold level. Players will only be allowed access to the aforementioned if they have legitimate medical conditions, and they are prescribed by a physician. Which is in accordance with the Tour’s Therapeutic Use Exemption (TUE) program.
PGA Tour Commissioner Jay Monahan announced the implementation of the new Anti-Doping Program, and issued the following statement:
“While we are extremely pleased with the implementation and results of the PGA Tour Anti-Doping Program to date, we believe that these changes to our program are prudent in that they further our objectives of protecting the well-being of our members and better substantiate the integrity of golf as a clean sport.”
Full revisions to the Program: www.pgatour.com/company/2017/06/19/pga-tour-revises-anti-doping-program.html
Related Articles
Gotterup opens PGA Tour season by winning Sony Open
World No.2 McIlroy needles LIV over recent signings



